Haiyan Si
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 21
- Pancreatic and Hepatic Oncology Research 9
- Cancer Immunotherapy and Biomarkers 8
- Colorectal Cancer Treatments and Studies 5
- Inflammatory Biomarkers in Disease Prognosis 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Chengjin Hu (4 shared papers)Yuan Cao (3 shared papers)Huan‐Chün Wang (1 shared paper)Xiaoming Sun (1 shared paper)Shimin Chen (1 shared paper)Yingjian Chen (2 shared papers)Miaomiao Gou (12 shared papers)Guanghai Dai (7 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Frontiers in Oncology (5 papers)Chemical Engineering Journal (2 papers)Scientific Reports (1 paper)BMC Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Haiyan Si
32 papers receiving 537 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 270
- Oncology 173
- Molecular Biology 292
- Hepatology 22
- Pulmonary and Respiratory Medicine 90
Countries citing papers authored by Haiyan Si
This map shows the geographic impact of Haiyan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Si more than expected).
Fields of papers citing papers by Haiyan Si
This network shows the impact of papers produced by Haiyan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Si. The network helps show where Haiyan Si may publish in the future.
Co-authors
The 25 scholars most cited alongside Haiyan Si, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 203 | |
| 2 | Long non-coding RNA H19 regulates cell growth and metastasis via miR-138 in breast cancer. | 2019 | 47 |
| 3 | 2019 | 32 | |
| 4 | 2021 | 27 | |
| 5 | 2018 | 27 | |
| 6 | 2022 | 26 | |
| 7 | 2020 | 26 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2021 | 15 | |
| 11 | 2022 | 13 | |
| 12 | 2014 | 11 | |
| 13 | 2014 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2013 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2025 | 6 | |
| 18 | 2015 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2022 | 5 |
About Haiyan Si
Haiyan Si is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Epidemiology and Cancer Research, having authored 36 papers that have together received 539 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Cancer Research (270 citations), Oncology (173 citations), Molecular Biology (292 citations), Hepatology (22 citations) and Pulmonary and Respiratory Medicine (90 citations). Haiyan Si has collaborated with scholars based in China. Frequent co-authors include Chengjin Hu, Yuan Cao, Huan‐Chün Wang, Xiaoming Sun, Shimin Chen, Yingjian Chen, Miaomiao Gou, Guanghai Dai, Zhikuan Wang and Niansong Qian. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Chemical Engineering Journal, Scientific Reports and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.